Lung Cancer ESMO 2024 Highlights: Key Studies Discussed LAURA, MARIPOSA, MARIPOSA-2, ADRIATIC

(16:10)

Expert report on neoadjuvant immune checkpoint inhibitors for NSCLC

(7:)

ESMO 2023 Lung Cancer Highlights – Keynote 671 | ALINA | TropionLung01 | Oncology Brothers

(18:24)

Expert video report on amivantamab in combination therapy for 1L treatment in EGFRm, advanced NSCLC

(5:18)

Lung ESMO 2022 Highlights - OncBrothers (Rohit and Rahul Gosain) with Dr. Joshua Reuss

(16:53)

#ESMO22 Highlights on actionable inflammatory axis for air pollution induced NSCLC

(3:35)

Lung cancer highlights from ESMO 2022

(1:6)

Oncogene-addicted NSCLC update from WCLC and ESMO 2024

(7:35)

ESMO Preceptorships – The Christie Lung Cancer Preceptorship Course

(1:54)

ESMO 2020 Expert Video Report on long term ICI outcomes in lung cancer

(10:9)

Lung ART trial updates from ESMO 2020

(2:27)

Highlights in lung cancer at ESMO 2022

(2:18)

ESMO 2024: Update on BRAF-altered lung cancer data

(4:45)

Raffaele Califano, ESMO 2018 – Mechanisms of resistance in non-small cell lung cancer

(6:35)

\

(1:29:29)

ESMO 2020 Highlights on 1st line lorlatinib for ALK+ NSCLC: The CROWN Study

(2:39)

Highlights on adjuvant alectinib in early ALK positive NSCLC: The ALINA study

(2:51)

ESMO 2024: Highlights and analysis

(24:35)